NLS Pharmaceutics AG

NasdaqCM:NLSP

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

🧠 Mental Health

💊 Pharmaceuticals

Location

Switzerland

Market Cap

USD 13.64 M

Share Price

USD 2.78

Avg Daily Volume

276,780

Change (1 day)

3.73%

Change (1 year)

-62.33%

Change (YTD)

31.75%

NLS Pharmaceutics AG Accounts Payable for the year ending August 22, 2025: N/A

NLS Pharmaceutics AG Accounts Payable is NA for the year ending August 22, 2025. Accounts payable are amounts owed by the company to suppliers or vendors for goods or services received but not yet paid.

Competitors

Eli Lilly and Company

USD 709.82

LLY

+4.38 0.62%

Neurocrine Biosciences, Inc.

USD 135.28

NBIX

+2.05 1.54%

Corcept Therapeutics Incorporated

USD 70.98

CORT

+0.58 0.82%

Jazz Pharmaceuticals plc

USD 120.53

JAZZ

+1.46 1.23%

H. Lundbeck A/S

USD 6.10

HLUN-B.CO

+0.04 0.64%

Axsome Therapeutics, Inc.

USD 117.14

AXSM

+0.15 0.13%

SK Biopharmaceuticals Co., Ltd.

USD 70.56

326030.KS

+1.45 2.10%

Alkermes plc

USD 29.06

ALKS

+0.09 0.31%

ACADIA Pharmaceuticals Inc.

USD 24.79

ACAD

-0.16 -0.62%

Indivior PLC

USD 24.05

INDV

-0.10 -0.41%

Supernus Pharmaceuticals, Inc.

USD 43.32

SUPN

+0.64 1.50%

Biohaven Ltd.

USD 14.68

BHVN

-0.02 -0.14%

AbbVie Inc.

USD 209.50

ABBV

+0.35 0.17%

Roche Holding AG

USD 339.30

RO.SW

-2.14 -0.63%

Novartis AG

USD 127.19

NOVN.SW

-0.09 -0.07%

View all

Key Data

Date	Accounts Payable	Short-Term Debt	Long-Term Debt	Total Liabilities